Taken together the authors speculate that as first line treatment for hypertension in glaucoma patients thiazides and/or to a lesser extent ACE inhibitors or β-blockers, depending on concomitant comorbidities as heart failure, lung or kidney disease, could be considered (rather than CCBs). This evidence concerns the gene ACE and kidney disorder.